Advances in the use of tocols as drug delivery vehicles.
about
Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their DerivativesTocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and FullerenesLiposomal Antioxidants for Protection against Oxidant-Induced DamageDifferential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model.An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistanceNanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal routeHydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability.Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxelNanomicellar carriers for targeted delivery of anticancer agents.Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions.Spectroscopic imaging studies of nanoscale polarity and mass transport phenomena in self-assembled organic nanotubes.Current trends in the use of vitamin E-based micellar nanocarriers for anticancer drug delivery.α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model.Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.Enhancement of intestinal absorption of 2-methyl cytidine prodrugs.Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol, and γ-tocopherol in rats."Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters.
P2860
Q26824259-15642CA9-3CED-42B0-A739-28E0B38C57D8Q28386610-E02518E0-700E-4A1F-B13F-186B6FB85135Q28391211-81B38E60-3DC6-4B79-ADF8-EE028CD84975Q33613579-18D916C2-0A9A-4828-B2F3-EE3000B22D5CQ34714270-16B5B9CE-70EA-4746-BECF-D5A9D6F6530EQ35182759-5806DF79-DB8D-4764-B804-DCD5625D21AAQ35634184-BA5F6FE9-65C3-47B4-BA71-1FB498E9F813Q35664762-8869CAA8-61DC-4491-B898-23B52B490610Q35913397-23DB6FD5-7809-4BDA-87EA-D0DF33CA5364Q36379940-8236CC47-B83B-48E2-A636-266EAADF01B3Q37185400-6EA17C3B-AFCA-43F2-B6CC-4FACD27767D4Q38171564-B3EAD68A-DDCE-47E0-883C-39BC5F280B37Q38202698-E655B82E-FE07-4F0B-B706-C707C9481C48Q38672367-819498B3-95BD-4FC0-A230-75CA57036AF4Q38937032-41FEB6BB-7E8A-497C-8655-B108089C550DQ42026315-9376922F-B32E-47DD-8DAD-735AB3AA84CAQ42366826-EE0CB841-8CF2-4B97-A6E3-D8D5B071A410Q42379723-36CFA9E2-5FE9-4A4F-99AF-53BB9B1BC8ECQ43127840-11AEE7E2-4867-4821-87F2-36F08DFCCCA1Q43410189-1B765DA6-CFCD-4F99-92C1-6EE10DB74ABBQ51354491-D5607A83-620C-4403-96FA-405A1D9A1103Q51372186-7F08A431-5F82-4635-8EAA-DEB24306F208
P2860
Advances in the use of tocols as drug delivery vehicles.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Advances in the use of tocols as drug delivery vehicles.
@ast
Advances in the use of tocols as drug delivery vehicles.
@en
type
label
Advances in the use of tocols as drug delivery vehicles.
@ast
Advances in the use of tocols as drug delivery vehicles.
@en
prefLabel
Advances in the use of tocols as drug delivery vehicles.
@ast
Advances in the use of tocols as drug delivery vehicles.
@en
P2093
P2860
P1476
Advances in the use of tocols as drug delivery vehicles.
@en
P2093
Jihong Han
Panayiotis P Constantinides
Stanley S Davis
P2860
P304
P356
10.1007/S11095-005-9262-9
P577
2006-01-25T00:00:00Z